Andrew W. Taylor

机构：Boston University, Amgen (United Kingdom) · ORCID：0000-0002-0330-8591

发表论文 306 篇 · 总被引 12446 次 · h-index 54

代表论文

• Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021 · The Lancet · 被引 567)
• Ocular Immune Privilege and Transplantation (2016 · Frontiers in Immunology · 被引 169)
• Negative regulators that mediate ocular immune privilege (2018 · Journal of Leukocyte Biology · 被引 100)
• The Role of Retinal Pigment Epithelial Cells in Regulation of Macrophages/Microglial Cells in Retinal Immunobiology (2021 · Frontiers in Immunology · 被引 68)
• Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases (2019 · Frontiers in Pharmacology · 被引 37)
• MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response (2016 · Scientific Reports · 被引 27)